+

PL2670394T3 - Układy do dostarczania nanocząstek, ich otrzymywanie i zastosowania - Google Patents

Układy do dostarczania nanocząstek, ich otrzymywanie i zastosowania

Info

Publication number
PL2670394T3
PL2670394T3 PL12702019T PL12702019T PL2670394T3 PL 2670394 T3 PL2670394 T3 PL 2670394T3 PL 12702019 T PL12702019 T PL 12702019T PL 12702019 T PL12702019 T PL 12702019T PL 2670394 T3 PL2670394 T3 PL 2670394T3
Authority
PL
Poland
Prior art keywords
preparation
delivery systems
nanoparticles delivery
nanoparticles
systems
Prior art date
Application number
PL12702019T
Other languages
English (en)
Inventor
Agnès Pottier
Laurent Levy
Marie-Edith MEYRE
Matthieu Germain
Original Assignee
Nanobiotix
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanobiotix filed Critical Nanobiotix
Publication of PL2670394T3 publication Critical patent/PL2670394T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A61K49/1812—Suspensions, emulsions, colloids, dispersions liposomes, polymersomes, e.g. immunoliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5115—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL12702019T 2011-01-31 2012-01-31 Układy do dostarczania nanocząstek, ich otrzymywanie i zastosowania PL2670394T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161437817P 2011-01-31 2011-01-31
EP11305096 2011-01-31
EP12702019.6A EP2670394B1 (en) 2011-01-31 2012-01-31 Nanoparticles delivery systems, preparation and uses thereof
PCT/EP2012/051507 WO2012104275A2 (en) 2011-01-31 2012-01-31 Nanoparticles delivery systems, preparation and uses thereof

Publications (1)

Publication Number Publication Date
PL2670394T3 true PL2670394T3 (pl) 2019-03-29

Family

ID=44202131

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12702019T PL2670394T3 (pl) 2011-01-31 2012-01-31 Układy do dostarczania nanocząstek, ich otrzymywanie i zastosowania

Country Status (13)

Country Link
US (1) US9956175B2 (pl)
EP (1) EP2670394B1 (pl)
JP (2) JP6158714B2 (pl)
KR (1) KR20140053843A (pl)
CN (1) CN103429227B (pl)
AU (1) AU2012213538A1 (pl)
CA (1) CA2825564A1 (pl)
DK (1) DK2670394T3 (pl)
EA (1) EA024930B1 (pl)
IL (1) IL227665A (pl)
PL (1) PL2670394T3 (pl)
WO (1) WO2012104275A2 (pl)
ZA (1) ZA201306464B (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8715150B2 (en) 2009-11-02 2014-05-06 Pulse Therapeutics, Inc. Devices for controlling magnetic nanoparticles to treat fluid obstructions
EA024930B1 (ru) 2011-01-31 2016-11-30 Нанобиотикс Системы доставки наночастиц, их получение и применение
JP2014503575A (ja) 2011-01-31 2014-02-13 ナノビオティックス 超常磁性のナノ粒子を用いて、興味対象生成物のリポソームからの放出をモニターする方法
EP2790682B1 (en) 2011-12-16 2019-03-20 Nanobiotix Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof
WO2014074475A1 (en) * 2012-11-07 2014-05-15 Emmetrope Ophthalmics Llc Magnetic eye shields and methods of treatment and diagnosis using the same
WO2014153160A2 (en) * 2013-03-14 2014-09-25 Peroxyium, Inc., Delaware C Corp. METHOD OF ENHANCING THE BIODISTRIBUTION AND TISSUE TARGETING PROPERTIES OF THERAPEUTIC CeO2 PARTICLES VIA NANO-ENCAPSULATION AND COATING
EP3003288A1 (en) * 2013-05-30 2016-04-13 Nanobiotix Pharmaceutical composition, preparation and uses thereof
WO2015169843A1 (en) 2014-05-06 2015-11-12 Glüer Claus-Christian Magnetoenzymatic carrier system for imaging and targeted delivery and release of active agents
DK3223796T3 (da) 2014-11-25 2021-09-27 Curadigm Sas Farmaceutiske sammensætninger, fremstilling og anvendelser deraf
LT3229776T (lt) 2014-11-25 2023-08-25 Curadigm Sas Farmacinė kompozicija, kurioje derinamos mažiausiai dvi skirtingos nanodalelės ir farmacinis mišinys, jos paruošimas ir vartojimas
US20170258718A1 (en) * 2014-11-25 2017-09-14 Nanobiotix Pharmaceutical composition, preparation and uses thereof
UA123665C2 (uk) * 2014-11-25 2021-05-12 Кюрадігм Сас Фармацевтична композиція, її одержання і застосування
AR102778A1 (es) 2014-11-25 2017-03-22 Nanobiotix Composición farmacéutica, su preparación y sus usos
EA201792560A1 (ru) 2015-05-28 2018-06-29 Нанобиотикс Наночастицы для применения в качестве терапевтической вакцины
CN105902400B (zh) * 2016-06-17 2019-10-11 四川百奥可生物科技有限责任公司 一种包裹生物酶的微粒及其制备方法和应用
ES2991899T3 (es) 2017-12-19 2024-12-05 Nanobiotix Nanopartículas para su uso para el tratamiento de un trastorno neuronal
HUE069335T2 (hu) 2017-12-19 2025-02-28 Nanobiotix Nanorészecskék agyi teljesítmény növelésére vagy stressz kezelésére
US11918315B2 (en) * 2018-05-03 2024-03-05 Pulse Therapeutics, Inc. Determination of structure and traversal of occlusions using magnetic particles
CN109387641B (zh) * 2018-12-20 2022-04-15 深圳职业技术学院 一种以磁性氧化铁纳米粒子为信号放大器检测天蚕素b的装置及检测方法
JP2023504525A (ja) * 2019-12-05 2023-02-03 ザ ジェネラル ホスピタル コーポレイション 調整可能な磁性ナノ粒子のための組成物および方法
WO2023186923A1 (en) 2022-03-30 2023-10-05 Meta Materials Inc. Implanted agent delivery system
CN115558100B (zh) * 2022-09-30 2023-12-22 桂林理工大学 一种改性透射电镜载网及其制备方法与应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4672040A (en) * 1983-05-12 1987-06-09 Advanced Magnetics, Inc. Magnetic particles for use in separations
US5225212A (en) * 1989-10-20 1993-07-06 Liposome Technology, Inc. Microreservoir liposome composition and method
EP0645048A1 (en) * 1992-06-08 1995-03-29 BioQuest Incorporated Preparation of controlled size inorganic particles for use in separations, as magnetic molecular switches, and as inorganic liposomes for medical applications
US6726925B1 (en) * 1998-06-18 2004-04-27 Duke University Temperature-sensitive liposomal formulation
US7769423B2 (en) 2002-09-11 2010-08-03 Duke University MRI imageable liposomes for the evaluation of treatment efficacy, thermal distribution, and demonstration of dose painting
NO329127B1 (no) 2006-09-12 2010-08-30 Epitarget As Sporbart partikulaert materiale for legemiddelavlevering omfattende et matriseeller membranmateriale, et legemiddel, og et T1- og et T2*- magnetisk resonanskontrastmiddel
NO20064315L (no) 2006-09-22 2008-03-24 Epitarget As T1 MRI-sporbare medikamentavleveringspartikler and anvendelse derav
US20090004258A1 (en) * 2007-06-27 2009-01-01 National Health Research Institutes Drug Release from Thermosensitive Liposomes by Applying an Alternative Magnetic Field
EP2067485A1 (en) 2007-12-07 2009-06-10 Koninklijke Philips Electronics N.V. Drug carrier providing MRI contrast enhancement
EA024930B1 (ru) 2011-01-31 2016-11-30 Нанобиотикс Системы доставки наночастиц, их получение и применение
JP2014503575A (ja) 2011-01-31 2014-02-13 ナノビオティックス 超常磁性のナノ粒子を用いて、興味対象生成物のリポソームからの放出をモニターする方法

Also Published As

Publication number Publication date
JP2014510040A (ja) 2014-04-24
DK2670394T3 (en) 2019-01-14
CN103429227B (zh) 2017-12-19
IL227665A0 (en) 2013-09-30
CN103429227A (zh) 2013-12-04
AU2012213538A2 (en) 2013-09-26
US9956175B2 (en) 2018-05-01
IL227665A (en) 2017-03-30
WO2012104275A2 (en) 2012-08-09
WO2012104275A3 (en) 2012-11-01
AU2012213538A1 (en) 2013-08-15
JP6158714B2 (ja) 2017-07-05
ZA201306464B (en) 2014-04-30
JP2017193550A (ja) 2017-10-26
EA201391119A1 (ru) 2014-01-30
CA2825564A1 (en) 2012-08-09
EA024930B1 (ru) 2016-11-30
EP2670394B1 (en) 2018-11-21
EP2670394A2 (en) 2013-12-11
US20140056813A1 (en) 2014-02-27
KR20140053843A (ko) 2014-05-08

Similar Documents

Publication Publication Date Title
ZA201306464B (en) Nanoparticles delivery systems,preparation and uses thereof
EP2841138A4 (en) AEROSOL LABELING SYSTEMS, COMPOSITIONS AND METHOD
EP2673025A4 (en) Improvements in infusion systems
PL3295812T3 (pl) Artykuły do palenia oraz inne doprowadzające przepływ artykuły
GB201511172D0 (en) Devices, systems and methods for locating and interacting with medicament delivery systems
GB201121069D0 (en) Delivery system
EP2663749A4 (en) Reductant delivery device
EP2709712A4 (en) HOSE DILATOR SYSTEM AND USES THEREOF
EP2683431A4 (en) DRUG DELIVERY SYSTEM
ZA201207900B (en) Fast dissolving drug delivery systems
IL221448A0 (en) Therapeutic delivery devices, systems, and methods
EP2717858A4 (en) COMBINATION PEPTID NANOPARTICLES AND DISPENSING SYSTEMS THEREWITH
PL2665431T3 (pl) Technika dostarczania leków
ZA201401210B (en) Peptide nanoparticles and uses thereof
EP2687539A4 (en) ANNEXIN V VERSION, ITS MANUFACTURE AND USE
ZA201309156B (en) Drug delivery system
SMT201800450T1 (it) Tecnologia di rilascio di farmaci
PT2790739T (pt) Nanopartículas e utilizações das mesmas
SG10201609440WA (en) Multi-additive delivery system
EP2766183A4 (en) IRON FIBER COMPOSITION, PREPARATION THEREOF AND USES THEREOF
SG11201402631YA (en) Methods and systems for catalyst delivery
GB201002962D0 (en) Microfluidic delivery systems
PT2670394T (pt) Sistemas de distribuição de nanopartículas, preparação e utilizações destes
HK40108463A (en) Lipidic nanoparticles for mrna delivery
HK1192157A (en) Nanoparticles delivery systems, preparation and uses thereof
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载